Session Information
2013 Summer Meeting
Click here to go to the previous page
Public Policy Issues and Priorities for Congress, Agencies and the States
Track:
Education Sessions (CE)
Program Code: 105-L03
Date: Monday, June 3, 2013
Time: 2:00 PM to 3:00 PM EST
Location:
101 J, Level 1
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Joseph Hill, MA, Director, Federal Legislative Affairs, American Society of Health-System Pharmacists Brian Meyer
Kasey Thompson
Christopher Topoleski
PROGRAM CHAIR:
Mr. Brian Meyer, MBA, Director, Government Affairs Division, American Society of Health-System Pharmacists
Description
This session will explore the critical issues facing health-system pharmacists in Congress, federal agencies and the states. Potential action on both the state and federal level in response to the meningitis outbreak, the lingering problem of drug shortages and efforts to achieve provider status will highlight the session.
- Describe the federal and state role in regulating compounding, managing and mitigating drug shortages, and participating in the 340B drug discount program.
- Explain the current approval pathway for biosimilars and state activity with respect to product interchangeability.
- Identify current federal regulatory and legislative issues impacting health-system pharmacists in a variety of settings.
| No items are available for this session. |